Greenbaum, C
They suggest that semaglutides benefits may extend beyond blood sugar control and weight loss to include potential improvements in mood and behavior regulation, thanks to its interaction with dopamine pathways
Batch-specific guidance For laboratory research use only (RUO)
Advances in preclinical modeling, including the use of organoid cultures, 3D-bioprinted tumors, and humanized mouse models, will enhance the physiological relevance of testing platforms and support more reliable translation into clinical settings
Anyone with a history of gastroparesis (slow gastric motility) or pancreatitis is not a good candidate for these medications, Eliszewski adds
Acknowledgements Dsire Lie, University of California, Irvine, CA, is the author of and is solely responsible for the content of the learning objectives, questions and answers of the MedscapeCME-accredited continuing medical education activity associated with this article